Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.

Numata, M; Nakayama, M; Hosoya, T; Hoff, C M; Holmes, C J; Schalling, M; Nordfors, L; Lindholm, B

Numata, M; Nakayama, M; Hosoya, T; Hoff, C M; Holmes, C J; Schalling, M; Nordfors, L; Lindholm, B.

Affiliation

Numata M; Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan. mnumata@jikei.ac.jp

Clin Nephrol ; 62(6): 455-60, 2004 Dec.

Article in En | MEDLINE | ID: mdl-15630905

Subject(s)

Glycation End Products, Advanced/metabolism; Peritoneal Dialysis, Continuous Ambulatory/adverse effects; Peritoneal Diseases/genetics; Receptors, Immunologic/genetics; Adult; Aged; Female; Genotype; Humans; Male; Middle Aged; Nitric Oxide Synthase/genetics; Nitric Oxide Synthase Type III; Peritoneal Diseases/pathology; Peritoneum/pathology; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptor for Advanced Glycation End Products; Sclerosis; Vascular Endothelial Growth Factor A/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Diseases / Receptors, Immunologic / Peritoneal Dialysis, Continuous Ambulatory / Glycation End Products, Advanced Type of study: Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2004 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links